Page last updated: 2024-10-18

kynurenine and Carcinoma, Basal Cell

kynurenine has been researched along with Carcinoma, Basal Cell in 1 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lo, BK1
Jalili, RB1
Zloty, D1
Ghahary, A1
Cowan, B1
Dutz, JP1
Carr, N1
Shapiro, J1
McElwee, KJ1

Other Studies

1 other study available for kynurenine and Carcinoma, Basal Cell

ArticleYear
CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes.
    The British journal of dermatology, 2011, Volume: 165, Issue:5

    Topics: Carcinoma, Basal Cell; DNA, Complementary; Female; Humans; Immunohistochemistry; Indoleamine-Pyrrole

2011